162 related articles for article (PubMed ID: 8863370)
1. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.
Krüger W; Sobottka I; Stockschläder M; Mross K; Hoffknecht M; Rüssmann B; Horstmann M; Betker R; Zander A
Scand J Infect Dis; 1996; 28(3):313-6. PubMed ID: 8863370
[TBL] [Abstract][Full Text] [Related]
2. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
[TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
Coukell AJ; Brogden RN
Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
[TBL] [Abstract][Full Text] [Related]
4. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report.
Gokhale PC; Barapatre RJ; Advani SH; Kshirsagar NA; Pandya SK
J Cancer Res Clin Oncol; 1993; 119(10):569-71. PubMed ID: 8335676
[TBL] [Abstract][Full Text] [Related]
6. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
[TBL] [Abstract][Full Text] [Related]
7. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review.
Evdoridou J; Roilides E; Bibashi E; Kremenopoulos G
Infection; 1997; 25(2):112-6. PubMed ID: 9108188
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ
Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
[TBL] [Abstract][Full Text] [Related]
9. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
11. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER; Chetchotisakd P; da Cunha CA; Ruhnke M; Barrios C; Raghunadharao D; Sekhon JS; Freire A; Ramasubramanian V; Demeyer I; Nucci M; Leelarasamee A; Jacobs F; Decruyenaere J; Pittet D; Ullmann AJ; Ostrosky-Zeichner L; Lortholary O; Koblinger S; Diekmann-Berndt H; Cornely OA;
Lancet; 2007 May; 369(9572):1519-1527. PubMed ID: 17482982
[TBL] [Abstract][Full Text] [Related]
12. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hepatosplenic candidiasis with liposomal amphotericin B in a patient with acute leukemia; a case report of the experience of use of liposomal amphotericin B].
Hasegawa T; Hiyoshi M; Aoyama Y; Sakamoto C; Ohta K; Yamane T; Hino M; Tatsumi N
Kansenshogaku Zasshi; 1998 Jun; 72(6):635-7. PubMed ID: 9695475
[TBL] [Abstract][Full Text] [Related]
14. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B in neonates with invasive candidiasis.
Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
[TBL] [Abstract][Full Text] [Related]
16. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
Kretschmar M; Nichterlein T; Hannak D; Hof H
Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.
Veldman BA; Verweij PE; Blijlevens NM
Neth J Med; 2006 Apr; 64(4):127-9. PubMed ID: 16609161
[TBL] [Abstract][Full Text] [Related]
18. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
19. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
Kriván G; Sinkó J; Nagy IZ; Goda V; Reményi P; Bátai A; Lueff S; Kapás B; Réti M; Tremmel A; Masszi T
Acta Biomed; 2006; 77 Suppl 2():17-21. PubMed ID: 16918062
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
